Clinical Trials in Chanute, United States
Locations / Chanute, United States
Delta Trials hosts 25 clinical trials conducted in Chanute, United States, making it a notable site of clinical research activity. These trials covering 234 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Chanute.
25
Total Trials
234
Conditions
0
Terminated since 2020
Browse by condition (234 total)
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- All Minimally invasive lung adenocarcinoma trials
- All Lung non-squamous non-small cell carcinoma trials
- Acute lymphoblastic leukemia 2 trialsAll Acute lymphoblastic leukemia trials
- Stage iii breast cancer ajcc v7 2 trialsAll Stage iii breast cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 2 trialsAll Stage iiia lung cancer ajcc v8 trials
- Bladder adenocarcinoma 2 trialsAll Bladder adenocarcinoma trials
- All Stage iv cutaneous melanoma ajcc v6 and v7 trials
- Stage iiib breast cancer ajcc v7 2 trialsAll Stage iiib breast cancer ajcc v7 trials
- Invasive breast carcinoma 2 trialsAll Invasive breast carcinoma trials
- Stage iii cutaneous melanoma ajcc v7 2 trialsAll Stage iii cutaneous melanoma ajcc v7 trials
- Stage iiib lung cancer ajcc v8 2 trialsAll Stage iiib lung cancer ajcc v8 trials
- All B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1 trials
- Chromophobe renal cell carcinoma 1 trialAll Chromophobe renal cell carcinoma trials
- Paranasal sinus adenocarcinoma 1 trialAll Paranasal sinus adenocarcinoma trials
- Stage iv penile cancer ajcc v8 1 trialAll Stage iv penile cancer ajcc v8 trials
- Stage ia breast cancer ajcc v7 1 trialAll Stage ia breast cancer ajcc v7 trials
- Colon adenocarcinoma 1 trialAll Colon adenocarcinoma trials